Our pan-cancer analysis revealed that ALDOA is significantly upregulated across multiple cancer types, including lung squamous cell carcinoma, liver hepatocellular carcinoma, bladder cancer, and ovarian cancer. This evidence concerns the gene ALDOA and urinary bladder cancer.